4//SEC Filing
KURLAND FRED 4
Accession 0001493152-22-034678
CIK 0001614067other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:59 AM ET
Size
5.5 KB
Accession
0001493152-22-034678
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-12-05+8,000→ 8,000 total→ Common Stock (8,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]4,000 shares of Common Stock will vest on June 5, 2023 and 4,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001267273
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 8:59 AM ET
- Size
- 5.5 KB